IRIS
TENTORI, LUCIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 52.057
EU - Europa 6.248
AS - Asia 4.882
SA - Sud America 596
Continente sconosciuto - Info sul continente non disponibili 240
AF - Africa 66
OC - Oceania 10
Totale 64.099
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 51.887
SG - Singapore 2.369
IT - Italia 2.032
CN - Cina 1.087
DE - Germania 763
UA - Ucraina 737
RU - Federazione Russa 546
FR - Francia 514
BR - Brasile 491
IE - Irlanda 427
HK - Hong Kong 399
VN - Vietnam 342
SE - Svezia 273
PL - Polonia 245
GB - Regno Unito 240
FI - Finlandia 217
JP - Giappone 152
KR - Corea 147
BD - Bangladesh 105
NL - Olanda 103
CA - Canada 95
IN - India 65
MX - Messico 41
CZ - Repubblica Ceca 34
ID - Indonesia 34
AR - Argentina 31
CO - Colombia 24
ES - Italia 23
TR - Turchia 23
AT - Austria 20
IQ - Iraq 18
BE - Belgio 17
ZA - Sudafrica 17
EG - Egitto 14
VE - Venezuela 14
IL - Israele 13
LT - Lituania 13
PK - Pakistan 13
UZ - Uzbekistan 13
PH - Filippine 12
JM - Giamaica 11
MY - Malesia 11
BG - Bulgaria 10
CH - Svizzera 10
CL - Cile 10
EC - Ecuador 10
TN - Tunisia 10
AU - Australia 9
IR - Iran 9
MA - Marocco 9
EU - Europa 8
KE - Kenya 8
AE - Emirati Arabi Uniti 7
KG - Kirghizistan 7
KZ - Kazakistan 6
SA - Arabia Saudita 6
TW - Taiwan 6
JO - Giordania 5
PE - Perù 5
PS - Palestinian Territory 5
PY - Paraguay 5
TT - Trinidad e Tobago 5
AL - Albania 4
MK - Macedonia 4
NP - Nepal 4
TH - Thailandia 4
UY - Uruguay 4
BH - Bahrain 3
DK - Danimarca 3
GT - Guatemala 3
NI - Nicaragua 3
OM - Oman 3
SY - Repubblica araba siriana 3
CR - Costa Rica 2
DO - Repubblica Dominicana 2
GE - Georgia 2
HN - Honduras 2
HR - Croazia 2
HU - Ungheria 2
KH - Cambogia 2
LB - Libano 2
MW - Malawi 2
PT - Portogallo 2
AM - Armenia 1
AZ - Azerbaigian 1
BN - Brunei Darussalam 1
BS - Bahamas 1
BY - Bielorussia 1
CY - Cipro 1
DZ - Algeria 1
EE - Estonia 1
GD - Grenada 1
GH - Ghana 1
GN - Guinea 1
GY - Guiana 1
HT - Haiti 1
KY - Cayman, isole 1
LC - Santa Lucia 1
LV - Lettonia 1
MD - Moldavia 1
Totale 63.857
Salva come PNG Salva come JPEG
Città #
Woodbridge 15.644
Wilmington 12.699
Houston 12.649
Ann Arbor 1.419
Singapore 1.265
Fairfield 1.117
Ashburn 901
Jacksonville 665
Chandler 621
San Jose 495
Seattle 445
Beijing 405
Dublin 401
Hong Kong 391
Cambridge 376
Rome 324
Medford 312
New York 297
Council Bluffs 240
Dearborn 228
Kraków 216
Santa Clara 213
Dallas 201
Milan 167
The Dalles 160
Lawrence 149
Los Angeles 140
Tokyo 114
Mülheim 113
Ho Chi Minh City 105
Buffalo 84
Moscow 77
Hanoi 69
Helsinki 67
Menlo Park 67
Zhengzhou 67
San Diego 59
Lauterbourg 56
Guangzhou 50
Boardman 47
Chicago 45
São Paulo 44
Mountain View 42
Frankfurt am Main 35
Redwood City 35
Shanghai 35
Munich 34
Phoenix 34
Atlanta 33
Falls Church 33
Civitavecchia 32
Naples 32
Nuremberg 32
Columbus 28
San Francisco 28
San Mateo 28
London 26
Palo Alto 26
University Park 26
Nanjing 25
Turin 25
Bari 22
Hefei 22
Prague 22
Verona 22
Jakarta 21
Palermo 21
Toronto 21
Brooklyn 20
Catania 20
Florence 20
Denver 19
Montreal 19
Norwalk 19
Orem 19
Ottawa 18
Rio de Janeiro 17
Bologna 15
Boston 15
Brescia 15
Brussels 15
Da Nang 15
Kansas City 15
Mexico City 15
Kunming 14
North Bergen 14
Porto Alegre 14
Saint Petersburg 14
Stockholm 14
Johannesburg 13
Nanchang 13
Redondo Beach 13
Brasília 12
Danville 12
Napoli 12
Tashkent 12
Warsaw 12
Belo Horizonte 11
Indiana 11
Pisa 11
Totale 54.422
Salva come PNG Salva come JPEG
Nome #
Gli inibitori della poli (ADP-ribosio) polimerasi (PARP) per superare la chemioresistenza a metilanti e inibitori di topoisomerasi I 1.597
L’attività fisica come terapia complementare: l’esempio delle malattie oncologiche 783
Temozolomide: An Update on Pharmacological Strategies to Increase its Antitumour Activity 652
Doping with growth hormone/IGF-1, anabolic steroids or erythropoietin: is there a cancer risk? 608
Common fragile sites in colon cancer cell lines: role of mismatch repair, RAD51 and poly(ADP-ribose) polymerase-1 539
Cilengitide down-modulates invasiveness and vasculogenic mimicry of neuropilin-1 expressing melanoma cells through the inhibition of αvβ5 integrin. 530
Valproic acid increases the stimulatory effect of estrogens on proliferation of human endometrial adenocarcinoma cells 518
Combined effects of adenovirus-mediated wild-type p53 transduction, temozolomide and poly (ADP-ribose) polymerase inhibitor in mismatch repair deficient and non-proliferating tumor cells 505
Targeted therapy for brain tumours: role of PARP inhibitors 503
Antitumor and antimetastatic effects of dacarbazine combined with cyclophosphamide and interleukin-2 in Lewis lung carcinoma (3LL) 498
Poly(ADP-ribose) polymerase inhibitor increases growth inhibition and reduces G2/M cell accumulation induced by temozolomide in malignant glioma cells 491
Ellagic acid inhibits bladder cancer invasiveness and in vivo tumor growth 491
A new water soluble MAPK activator exerts antitumor activity in melanoma cells resistant to the BRAF inhibitor vemurafenib 488
Stable depletion of poly (ADP-ribose) polymerase-1 reduces in vivo melanoma growth and increases chemosensitivity 483
Poly(ADP-ribose) glycohydrolase inhibitor as chemosensitiser of malignant melanoma for temozolomide 483
A novel water-soluble nitrobenzoxadiazole is highly effective against vemurafenib-resistant human melanoma cells 480
Combined treatment with temozolomide and poly(ADP-ribose) polymerase inhibitor enhances survival of mice bearing hematologic malignancy at the central nervous system site 479
Challenging resistance mechanisms to therapies for metastatic melanoma 475
Chemical xenogenization: antigenic changes of cancer cells induced by triazene compounds 474
Apoptotic and genotoxic effects of a methyl sulfonate ester that selectively generates N3-methyladenine and poly(ADP-ribose) polymerase inhibitors in normal peripheral blood lymphocytes 472
Role of the mismatch repair system and p53 in the clastogenicity and cytotoxicity induced by bleomycin 471
Immunopharmacology of antitumor agents. 471
Experimental evidence of the antitumor, antimetastatic and antiangiogenic activity of ellagic acid 471
Brain distribution and efficacy as chemosensitizer of an oral formulation of PARP-1 inhibitor GPI 15427 in experimental models of CNS tumors. 470
Una medicina che cambia: l’approccio all’ipercolesterolemia. 463
The integrin antagonist cilengitide increases the antitumor activity of temozolomide against malignant melanoma 462
Exploiting Microglial Functions for the Treatment of Glioblastoma 461
Mutation of the mismatch repair gene hMSH2 and hMSH6 in a human T-cell leukemia line tolerant to methylating agents 460
Effects of single or split exposure of leukemic cells to temozolomide, combined with poly(ADP-ribose) polymerase inhibitors on cell growth, chromosomal aberrations and base excision repair components 460
Treatment with temozolomide and poly(ADP-ribose) polymerase inhibitors induces early apoptosis and increases base excision repair gene transcripts in leukemic cells resistant to triazene compounds 460
New aspects of immune responses against mycobacteria: immunopharmacology studies 459
Pharmacological strategies to increase the antitumor activity of methylating agents 458
Rifampin increases cytokine-induced expression of the CD1b molecule in human peripheral blood monocytes 456
Influence of low-dose beta-interferon on natural killer cell activity in breast cancer patients subjected to chemotherapy 455
Cytokine-induced expression of CD1b molecules by peripheral blood monocytes: influence of 3'-azido-3'-deoxythymidine 455
Novel Glutathione S-Transferase Inhibitor Enhances Temozolomide Efficacy Against Malignant Melanoma 52nd Annual Meeting of the Italian Cancer Society. Lost in translation: bridging the gap between cancer research and effective therapies 454
Oral administration of PARP inhibitor GPI 18180 increases the anti-tumor activity of temozolomide against intracranial melanoma in mice. 454
Modulation of GDF11 expression and synaptic plasticity by age and training 454
Cytokine-induced expression of CD1b molecules by peripheral blood monocytes: Influence of 3'-azido-3'-deoxythymidine 453
The glutathione transferase inhibitor 6-(7-nitro-2,1,3-benzoxadiazol-4-ylthio)hexanol (NBDHEX) increases temozolomide efficacy against malignant melanoma 452
Comparative studies between in vitro and in vivo effects of human beta-interferon on natural killer activity and its relevance to immunochemotherapy 450
Induction of apoptosis in thymocytes by prostaglandin E2 in vivo 448
Thymic selection of the T-cell repertoire 445
Chemotherapy in hairy cell leukemia. Preliminary results of a nonaggressive regimen 444
Effects of diheptyldiselenide (DDS) on human tumor cell lines and on peripheral blood mononuclear cells 442
Role of PARP, NF-kB and telomerase in necrosis induced by selective methylation of N3-adenine. 442
Differentiation of Ia-reactive CD8+ murine T cells does not require Ia engagement. Implications for the role of CD4 and CD8 accessory molecules in T cell differentiation 441
Monoclonal antibodies to CTLA-4 with focus on ipilimumab 439
Drug-mediated increase of susceptibility of human lung cancer to NK or LAK effector cells 439
Triazene compounds induce apoptosis in O6-alkylguanine-DNA alkyltransferase deficient leukemia cell lines 438
Potential clinical applications of poly(ADP-ribose) polymerase (PARP) inhibitors 438
Pharmacological inhibition of poly(ADP-ribose) polymerase-1 modulates resistance of human glioblastoma stem cells to temozolomide. 438
Antitumor activity of a novel anti-vascular endothelial growth factor receptor-1 monoclonal antibody that does not interfere with ligand binding 438
Apoptotic and clastogenic effects of methylating agents, alone or combined with poly(ADP-ribose) polymerase inhibitor, in peripheral blood lymphocytes 437
Role of DNA repair pathways in the control of common fragile sites expression. 437
PARP1 is activated at telomeres upon G4 stabilization: possible target for telomere-based therapy 436
Mutations of human DNA topoisomerase I at poly(ADP-ribose) binding sites: modulation of camptothecin activity by ADP-ribose polymers. 436
DNA damaging agents can induce celll cycle arrest in different phases of mitosis 435
Activity against melanoma of an anti-vascular endothelial growth factor receptor-1 (VEGFR-1) monoclonal antibody that does not hamper ligand binding 434
Inhibition of O-6-alkylguanine DNA-alkyltransferase or poly(ADP-ribose) polymerase increases susceptibility of leukemic coils to apoptosis induced by temozolomide 433
Pharmacological Inhibition of Poly(ADP-ribose) Polymerase (PARP) Activity in PARP-1 Silenced Tumour Cells Increases Chemosensitivity to Temozolomide and to a N3-Adenine Selective Methylating Agent. 433
IL-2 reverses the inhibition of cytotoxic T-cell responses induced by 5-(3,3' dimethyl-1-triazeno)-imidazole-4-carboxamide (DTIC) in vitro 433
Poly (ADP-ribose) polymerase (PARP) inhibition or PARP-1 gene deletion reduces angiogenesis 433
Doping and Cancer 432
Ipilimumab: A novel immunostimulatory monoclonal antibody for the treatment of cancer 431
Poly(ADP-ribose) polymerase (PARP) inhibition or PARP-1 gene deletion reduces angiogenesis 431
Effect of rifampin on CD1b expression and double-negative T cell responses against mycobacteria-derived glycolipid antigen 430
Cytotoxic and clastogenic effects of a DNA minor groove binding methyl sulfonate ester in mismatch repair deficient leukemic cells 430
VEGFR-1 derived peptide specifically inhibits PlGF and VEGF-B-induced migration of endothelial cells and in vivo angiogenesis. 429
Pharmacological inhibition of poly(ADP-ribose) polymerase activity down-regulates the expression of syndecan-4 and Id-1 in endothelial cells 428
Acute rejection of interferon-treated leukemia cells injected into lethally irradiated syngeneic mice 426
Neuropilin-1 expressing melanoma cells as a model to study the aggressiveness of metastatic melanoma 426
Influence of MLH1 on colon cancer sensitivity to poly(ADP-ribose) polymerase inhibitor combined with irinotecan. 425
Inhibition of telomerase increases resistance of melanoma cells to temozolomide, but not to temozolomide combined with poly (ADP-ribose) polymerase inhibitor 423
Primary cultures of microglial cells for testing toxicity of anticancer drugs. 423
Poly (ADP-ribose) polymerase inhibitor increases apoptosis and reduces necrosis induced by a DNA minor groove binding methyl sulfonate ester 422
MSH3 expression does not influence the sensitivity of colon cancer HCT116 cell line to oxaliplatin and poly(ADP-ribose) polymerase (PARP) inhibitor as monotherapy or in combination. 421
Pharmacological inhibition of poly (ADP-ribose) polymerase (PARP) activity down-regulates the expression of syndecan-4 and Id-1 in endothelial cells and increases temozolomide sensitivity of PARP-1 silenced melanoma cells. 418
Platelet-derived growth factor C and calpain-3 are modulators of human melanoma cell invasiveness. 418
Acquired hemoglobin H disease in a case of refractory anemia with excess of blasts (RAEB) evolving into acute nonlymphoid leukemia 415
Residual telomerase activity: a marker of cell survival after exposure to gamma radiation in vitro 415
Evidence that corticotropin-releasing hormone inhibits cell growth of human breast cancer cells via the activation of CRH-R1 receptor subtype. 414
The anti-vascular endothelial growth factor receptor-1 monoclonal antibody D16F7 inhibits invasiveness of human glioblastoma and glioblastoma stem cells 413
Oral administration of the PARP-1 inhibitor GPI 15427 increases the anti-tumor activity of irinotecan against colon carcinomas 411
Inhibition of metastasis induced by triazene derivatives in mice bearing Lewis Lung Carcinoma (3LL): role of protein kinase C 411
Mutation of the mismatch repair gene hMSH2 and hMSH6 in a human T-cell leukemia line tolerant to methylating agents 409
Oral administration of the PARP-1 inhibitor GPI 15427 increases the anti-tumor activity of irinotecan and temozolomide combination against colon carcinoma 409
Inhibition of poly(ADP-ribose) polymerase (PARP) increases the therapeutic efficacy of the G-quadruplex ligand RHPS4/irinotecan combination in colon cancer xenografts 409
In vivo anti-angiogenic potential of a peptide that inhibits VEGFR-1 homodimerization and PlGF-induced migration of endothelial cells. 408
Systemic administration of the PARP inhibitor GPI 15427 increases the anti-tumor activity of temozolomide in melanoma, glioma and lymphoma preclinical models in vivo 408
Proliferation and production of IL-2 and B cell stimulatory factor 1/IL-4 in early fetal thymocytes by activation through Thy-1 and CD3 408
In vitro antitumor activity of 3'-desamino-3'(2-methoxy-4-morpholinyl) doxorubicin on human melanoma cells sensitive or resistant to triazene compounds 408
Evidence of the crucial role of the linker domain on the catalytic activity of human topoisomerase I by experimental and simulative characterization of the Lys681Ala mutant 406
Influenza di farmaci antivirali o antimicobatterici sulla proliferazione di monociti umani e sulla espressione del CD1b. Secondo Progetto di ricerca Tubercolosi 406
PARP inhibitors for cancer treatment: an update on current clinical trials. 405
PARP-1 inhibitor: a novel approach to enhance efficacy of chemotherapy. 404
null 404
Chemopotentiation by PARP inhibitors in cancer therapy 403
Generation of an immortalized human endothelial cell line as a model of neovascular proliferating endothelial cells to assess chemosensitivity to anticancer drugs. 402
Inhibition of endothelial cell migration by vascular endothelial growth factor receptor-1 peptides. 401
Totale 46.219
Salva come PNG Salva come JPEG
Categoria #
all - tutte 130.450
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 130.450
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.430 0 214 110 66 32 110 95 68 106 107 76 446
2022/20231.923 202 107 61 268 115 430 163 97 180 41 176 83
2023/20241.176 100 36 81 65 109 342 86 60 47 47 65 138
2024/20253.572 139 858 398 208 136 312 150 192 350 181 323 325
2025/20265.609 407 252 776 334 490 179 601 731 665 659 238 277
2026/2027703 402 301 0 0 0 0 0 0 0 0 0 0
Totale 64.099